Stephen Worland

Stephen Worland

Grundare på
eFFECTOR Therapeutics Operations, Inc.
68 år
Health Technology
Consumer Services
Technology Services

Profil

Stephen T.
Worland
is the founder of eFFECTOR Therapeutics Operations, Inc., founded in 2012, where the title held is President, Chief Executive Officer & Director.
Current jobs include Chief Executive Officer & Director at Numerion Labs, Inc. since 2025, and Director at Blacksmith Medicines, Inc. since 2017.
Former jobs include President, Chief Executive Officer & Director at Anadys Pharmaceuticals, Inc. from 2007 to 2011; President, Chief Executive Officer & Director at eFFECTOR Therapeutics, Inc. from 2021 to 2024; VP-Antiviral Research & Director-Molecular Biology at Agouron Pharmaceuticals LLC from 1988 to 2001; Independent Non-Executive Director at GenMark Diagnostics, Inc. from 2013 to 2015; Director at Forge Therapeutics, Inc.; Independent Director at TRACON Pharmaceuticals, Inc. from 2015 to 2024; Vice President & Head-Antiviral Research at Pfizer Inc. from 2000 to 2001; and Vice President at Warner-Lambert Co. Education includes a doctorate from the University of California, Berkeley, and an undergraduate degree from the University of Michigan.

Aktiva positioner av Stephen Worland

FöretagPositionStart
Grundare 2012-05-01
Direktör/Styrelseledamot 2017-04-01
Verkställande Direktör 2025-02-18

Tidigare kända positioner av Stephen Worland

FöretagPositionSlut
TRACON PHARMACEUTICALS, INC. Direktör/Styrelseledamot 2024-07-31
EFFECTOR THERAPEUTICS, INC. Verkställande Direktör 2024-06-21
GENMARK DIAGNOSTICS, INC. Direktör/Styrelseledamot 2015-02-01
Verkställande Direktör 2011-11-23
Företagsledare/Principal 2001-01-01
Se detaljerna i Stephen Worlands erfarenhet

Stephen Worlands utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

56

Första gradens relationer

13

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Stephen Worland